TNP

GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal aims to enhance the health and quality of life for patients and families affected by these challenging conditions by providing cost-effective treatment options. Through its commitment to addressing the needs of those with intractable diseases, GEXVal strives to make a meaningful impact in the realm of healthcare.

PharmaBio Corporation is a health care company based in Nagoya, Japan, specializing in the contract development and manufacturing of cellular and tissue-based products. Established in 1978, the company focuses on developing cell-based investigational new drugs and provides a range of services, including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a Good Manufacturing Practice (GMP)-compliant facility for the storage of cell-based drugs and test specimens. Additionally, the company offers strategic development consultation and research services to support the regulatory development of cell and tissue-based medicine. By emphasizing safety and quality, PharmaBio aims to enhance the production of improved-quality medical products derived from living cells and tissues, contributing to advancements in regenerative medicine.

Allied Flow specializes in the development and manufacturing of a droplet cell sorter that is designed to decontaminate cells. The company focuses on the research and diagnostic equipment sector, utilizing flow cytometry technology. Its primary product facilitates aseptic operation and plays a critical role in the purification of stem cells, which are essential for cell therapy. By providing healthcare providers with an efficient method to prepare stem cells for therapeutic applications, Allied Flow supports advancements in medical treatments and enhances the overall quality of cell production processes.

GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal aims to enhance the health and quality of life for patients and families affected by these challenging conditions by providing cost-effective treatment options. Through its commitment to addressing the needs of those with intractable diseases, GEXVal strives to make a meaningful impact in the realm of healthcare.

PharmaBio Corporation is a health care company based in Nagoya, Japan, specializing in the contract development and manufacturing of cellular and tissue-based products. Established in 1978, the company focuses on developing cell-based investigational new drugs and provides a range of services, including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a Good Manufacturing Practice (GMP)-compliant facility for the storage of cell-based drugs and test specimens. Additionally, the company offers strategic development consultation and research services to support the regulatory development of cell and tissue-based medicine. By emphasizing safety and quality, PharmaBio aims to enhance the production of improved-quality medical products derived from living cells and tissues, contributing to advancements in regenerative medicine.

NORMEE Limited specializes in palm recognition technology that allows users to unlock their devices through unique palm patterns, including lines, ridges, veins, and capillaries. Utilizing the built-in camera of smartphones and tablets, NORMEE's system provides accurate authentication using standard visible-spectrum cameras. Founded in February 2005 and based in Tokyo, Japan, the company focuses on developing mobile biometrics technology that supports hybrid biometric authentication tailored to different operating environments. Formerly known as Universal Robot Co., Ltd., NORMEE aims to enhance security and user convenience in mobile device access.

Connectec Japan Corporation specializes in the development and provision of semiconductor and electrical products. Founded in 2009 and headquartered in Myoko, Japan, the company offers foundry services for semiconductor packaging, along with technical support for surface-mount technology (SMT). Additionally, it provides evaluation, analysis, and reliability testing services. Connectec Japan is recognized for its expertise in semiconductor chip bonding and low-temperature MEMS chips, as well as small desktop semiconductor assembly equipment. The company also supports device bonding on low-heat-resistant substrates and facilitates prototype development. With a satellite office in Kyoto and sales offices in Seoul, Korea, and Suzhou, China, Connectec Japan serves a diverse clientele across various industrial applications.

i cubed systems provides information technology-related solutions for mobile devices.

SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.

MiNO Wireless is a leading provider of managed alternative roaming services that enable mobile operators to capture revenue from budget conscious subscribers when they travel internationally. Through a seamless wireless network provided by MiNO's international mobile partnerships, mobile travelers have a local presence and enjoy a superior user experience that provides mobile voice, text and data coverage at very attractive rates.